Nan Shen
Impact in
- Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 0.5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- interferon and immune responses
Papers in
- Rheumatology 81
- Systemic Lupus Erythematosus Research 73
- Immunology 94
- T-cell and B-cell Immunology 29
- Immune Cell Function and Interaction 25
- interferon and immune responses 18
Nan Shen
244 papers receiving 10.9k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Cancer Research 3.0k
- Immunology 3.5k
- Rheumatology 1.9k
- Molecular Biology 5.1k
- Biochemistry 385
Countries citing papers authored by Nan Shen
This map shows the geographic impact of Nan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Shen more than expected).
Fields of papers citing papers by Nan Shen
This network shows the impact of papers produced by Nan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Shen. The network helps show where Nan Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nan Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 13 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 47 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 6 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 10 | |
| 16 | 2023 | 3 | |
| 17 | 2021 | 11 | |
| 18 | 2020 | 78 | |
| 19 | 2019 | 65 | |
| 20 | 2015 | 74 |
About Nan Shen
Nan Shen is a scholar working on Rheumatology, Immunology, Cancer Research, Nephrology and Molecular Biology, having authored 257 papers that have together received 11.0k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (73 papers), MicroRNA in disease regulation (31 papers), T-cell and B-cell Immunology (29 papers), Immune Cell Function and Interaction (25 papers), Cancer-related molecular mechanisms research (22 papers), Cytokine Signaling Pathways and Interactions (21 papers), interferon and immune responses (18 papers) and Circular RNAs in diseases (12 papers). The work is most often cited by research in Cancer Research (3.0k citations), Immunology (3.5k citations), Rheumatology (1.9k citations), Molecular Biology (5.1k citations) and Biochemistry (385 citations). Nan Shen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yuanjia Tang, Biao Jin, Lı Wang, Sian Liu, Quan Gan, Tongfei Wang, Huijuan Cui, Xiaobing Luo, Shun‐le Chen and Xinfang Huang. Their work appears in journals such as Arthritis & Rheumatology, Frontiers in Immunology, Arthritis Research & Therapy, Scientific Reports and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.